폐 또는 호흡기 약물전달 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 9.0%의 연평균 복합 성장률(CAGR)로 1,078억 5,000만 달러에 달할 것으로 예측됩니다. 예측 기간 중 맞춤형 의료에 대한 수요 증가, 만성 호흡기 질환의 확산, 원격의료에 대한 관심 증가, 헬스케어 인프라에 대한 투자 증가, 의약품 E-Commerce의 확대 등으로 인해 성장이 예상됩니다. 이 기간의 주요 동향으로는 입자 공학의 발전, 첨단 분무기 개발, 리포좀 제제 개발, 전산유체역학의 발전, 스마트 흡입기 혁신 등이 있습니다.
폐렴 발병률 증가는 폐 또는 호흡기 약물전달 시장의 성장을 촉진할 것으로 예측됩니다. 폐렴은 폐의 감염성 질환으로 기낭에 염증이 생겨 액체나 고름이 차고 기침, 발열, 호흡곤란 등의 증상이 나타나는 질환입니다. 폐렴 증가 요인으로는 인구 고령화, 면역력 저하, 호흡기 감염, 대기오염, 흡연, 항생제 내성균 증가 등을 들 수 있습니다. 폐 또는 호흡기 약물전달은 항생제, 기관지확장제, 항염증약 등의 약물을 폐에 직접 투여하여 폐렴 치료를 돕고 증상 완화, 염증 감소, 감염 제거, 호흡 기능 개선 등 회복을 돕고 합병증을 예방하기 위한 신속하고 효과적인 치료를 가능하게 합니다. 예를 들어 2023년 11월, 열대 의학 및 세계 보건 센터는 케냐의 폐렴 환자가 크게 증가하여 2022/2023년 기간 중 79만 3,864명에 이르렀다고 보고했습니다. 따라서 폐렴의 유병률 증가는 폐 또는 호흡기 약물전달 시장의 성장을 주도하고 있습니다.
폐 또는 호흡기 약물전달 시장의 기업은 치료 효과와 환자 순응도를 향상시키는 복합 약물전달 시스템과 같은 혁신에 집중하고 있습니다. 복합 약물전달 시스템은 치료제의 표적 전달과 제어된 방출을 강화하여 약물의 효능과 환자 결과를 향상시키는 첨단 기술입니다. 예를 들어 2023년 7월 미국 헬스케어 기업 Viatris Inc.와 약물전달 전문 기업 Kindeva Drug Delivery L.P.는 브리나(부데소니드 포모테롤 푸마르산염 이수화합물) 흡입용 에어로졸을 출시했습니다. 미국 식품의약국(FDA)의 승인을 받은 이 제품은 아스트라제네카 심비코트의 첫 번째 제네릭 의약품으로 부데소니드와 포르모테롤을 천식 및 만성폐쇄성폐질환 치료용 정량 흡입기에 혼합한 제품입니다. 강도는 80마이크로그램과 160마이크로그램 두 가지가 있으며, 포르모테롤은 4.5마이크로그램입니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 폐 또는 호흡기 약물전달 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 용도 산업의 분석
- 세계의 폐 또는 호흡기 약물전달 시장 : 성장률 분석
- 세계의 폐 또는 호흡기 약물전달 시장 실적 : 규모와 성장, 2019-2024
- 세계의 폐 또는 호흡기 약물전달 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계폐 또는 호흡기 약물전달 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 폐 또는 호흡기 약물전달 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 처방 유형
- 디바이스 유형
- 세계의 폐 또는 호흡기 약물전달 시장 : 캐니스터 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 플레인 캐니스터
- 코팅 캐니스터
- 세계의 폐 또는 호흡기 약물전달 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 만성 폐쇄성 폐질환
- 천식
- 낭포성 섬유증
- 기타 용도
- 세계의 폐 또는 호흡기 약물전달 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 클리닉
- 홈케어 설정
- 세계의 폐 또는 호흡기 약물전달 시장, 제제 유형의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 드라이 파우더 흡입기(DPI)
- 정량 분무식 흡입기(MDI)
- 네뷸라이저
- 액체 에어로졸
- 비강 스프레이
- 세계의 폐 또는 호흡기 약물전달 시장, 디바이스 유형의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 흡입기(수동식 및 디지털식)
- 네뷸라이저(컴프레서식, 초음파식, 메시식)
- 호흡 작동 기기
- 스페이서 디바이스
- 경비 약물전달 디바이스
제7장 지역별·국가별 분석
- 세계의 폐 또는 호흡기 약물전달 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 폐 또는 호흡기 약물전달 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 폐 또는 호흡기 약물전달 시장 : 경쟁 구도
- 폐 또는 호흡기 약물전달 시장 : 기업 개요
- Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- 3M Company
- Koninklijke Philips N.V.
- GlaxoSmithKline
- Omron Corporation
- Teva Pharmaceutical Industries Ltd.
- Aptar Pharma
- Sumitomo Pharma America Inc.
- Chiesi Farmaceutici S.p.A.
- Cipla Inc.
- Boehringer Ingelheim GmbH
- Kindeva Drug Delivery Limited
- Nemera Group
- Hovione
- H And T Presspart Group
- Vectura Group plc
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 폐 또는 호흡기 약물전달 시장 2029 : 새로운 기회를 제공하는 국가
- 폐 또는 호흡기 약물전달 시장 2029 : 새로운 기회를 제공하는 부문
- 폐 또는 호흡기 약물전달 시장 2029 : 성장 전략
제36장 부록
KSA
Pulmonary or respiratory drug delivery involves the direct administration of medication into the lungs to facilitate quick absorption, targeted treatment, and minimize systemic side effects, offering both local and systemic therapeutic benefits.
The primary categories of pulmonary or respiratory drug delivery include formulation type and device type. Formulation type pertains to the method of preparing drugs for efficient delivery, ensuring precise dosing and absorption in the body. Different canister options include plain and coated canisters, which are utilized for treating conditions such as chronic obstructive pulmonary disease, asthma, cystic fibrosis, and others. These devices are commonly used across various settings, including hospitals, clinics, and home care environments.
The pulmonary or respiratory drug delivery market research report is one of a series of new reports from The Business Research Company that provides pulmonary or respiratory drug delivery market statistics, including pulmonary or respiratory drug delivery industry global market size, regional shares, competitors with a pulmonary or respiratory drug delivery market share, detailed pulmonary or respiratory drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonary or respiratory drug delivery industry. This pulmonary or respiratory drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pulmonary or respiratory drug delivery market size has grown strongly in recent years. It will grow from $69.83 billion in 2024 to $76.38 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth during the historical period can be attributed to factors such as the increasing prevalence of asthma, greater adoption of advanced inhalation devices, a rise in global healthcare spending, growing awareness of respiratory diseases, and a higher incidence of allergic conditions.
The pulmonary or respiratory drug delivery market size is expected to see strong growth in the next few years. It will grow to $107.85 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. For the forecast period, growth is expected due to the rising demand for personalized medicine, the growing prevalence of chronic respiratory diseases, an increased focus on telemedicine, more investments in healthcare infrastructure, and the expansion of e-commerce for pharmaceutical products. Key trends during this period include advancements in particle engineering, the development of advanced nebulizers, the creation of liposomal formulations, progress in computational fluid dynamics, and the innovation of smart inhalers.
The rising incidence of pneumonia is expected to drive the growth of the pulmonary or respiratory drug delivery market. Pneumonia is a lung infection that causes inflammation in the air sacs, which may fill with fluid or pus, resulting in symptoms such as cough, fever, and difficulty breathing. Factors contributing to the increasing prevalence of pneumonia include aging populations, weakened immune systems, respiratory infections, air pollution, smoking, and the rise of antibiotic-resistant bacteria. Pulmonary or respiratory drug delivery helps treat pneumonia by directly delivering medications such as antibiotics, bronchodilators, or anti-inflammatory agents to the lungs, enabling quicker and more effective treatment to alleviate symptoms, reduce inflammation, clear infections, and improve respiratory function, thus aiding recovery and preventing complications. For example, in November 2023, the Centre for Tropical Medicine and Global Health reported a significant rise in pneumonia cases in Kenya, reaching 793,864 in the 2022/2023 period. As such, the increasing prevalence of pneumonia is driving the pulmonary or respiratory drug delivery market's growth.
Companies in the pulmonary or respiratory drug delivery market are focusing on innovations such as complex drug delivery systems that improve treatment efficacy and patient compliance. Complex drug delivery systems are advanced technologies that enhance the targeted delivery and controlled release of therapeutic agents, boosting drug effectiveness and patient outcomes. For example, in July 2023, Viatris Inc., a US-based healthcare company, and Kindeva Drug Delivery L.P., a US-based company specializing in drug delivery, launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol. Approved by the US Food and Drug Administration, this is the first generic version of AstraZeneca's Symbicort and combines budesonide and formoterol in a metered-dose inhaler for treating asthma and chronic obstructive pulmonary disease. It is available in two strengths, 80 micrograms and 160 micrograms, with 4.5 micrograms of formoterol.
In June 2022, Kindeva Drug Delivery acquired iPharma Labs Inc. for an undisclosed amount. This acquisition enhances Kindeva's capabilities in inhalation therapy development, allowing for improved formulation and manufacturing processes for respiratory medications. It also enables the company to offer comprehensive support to pharmaceutical clients from early-stage development to commercial production. iPharma Labs Inc. is a US-based company that specializes in pulmonary or respiratory drug delivery solutions.
Major players in the pulmonary or respiratory drug delivery market are Merck & Co. Inc., Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, 3M Company, Koninklijke Philips N.V., GlaxoSmithKline, Omron Corporation, Teva Pharmaceutical Industries Ltd., Aptar Pharma, Sumitomo Pharma America Inc., Chiesi Farmaceutici S.p.A., Cipla Inc., Boehringer Ingelheim GmbH, Kindeva Drug Delivery Limited, Nemera Group, Hovione, H And T Presspart Group, Vectura Group plc
North America was the largest region in the pulmonary or respiratory drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pulmonary or respiratory drug delivery report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the pulmonary or respiratory drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pulmonary or respiratory drug delivery market consists of sales of metered-dose inhalers (MDIs), dry powder inhalers (DPIs), nebulizers, aerosol formulations, and smart inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pulmonary Or Respiratory Drug Delivery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pulmonary or respiratory drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pulmonary or respiratory drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pulmonary or respiratory drug delivery market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Formulation Type, Device Type
- 2) By Canister Type: Plain Canister, Coated Canister
- 3) By Application: Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Other Applications
- 4) By End-User: Hospitals, Clinics, Home Care Settings
- Subsegments:
- 1) By Formulation Type: Dry Powder Inhalers (DPIs); Metered Dose Inhalers (MDIs); Nebulizers; Liquid Aerosols; Nasal Sprays
- 2) By Device Type: Inhalers (Manual and Digital); Nebulizers (Compressor, Ultrasonic, Mesh); Breath-Activated Devices; Spacer Devices; Nasal Drug Delivery Devices
- Companies Mentioned: Merck & Co. Inc.; Novartis AG; Thermo Fisher Scientific Inc.; AstraZeneca plc; Abbott Laboratories
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Pulmonary Or Respiratory Drug Delivery Market Characteristics
3. Pulmonary Or Respiratory Drug Delivery Market Trends And Strategies
4. Pulmonary Or Respiratory Drug Delivery Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Pulmonary Or Respiratory Drug Delivery Growth Analysis And Strategic Analysis Framework
- 5.1. Global Pulmonary Or Respiratory Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Pulmonary Or Respiratory Drug Delivery Market Growth Rate Analysis
- 5.4. Global Pulmonary Or Respiratory Drug Delivery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Pulmonary Or Respiratory Drug Delivery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Pulmonary Or Respiratory Drug Delivery Total Addressable Market (TAM)
6. Pulmonary Or Respiratory Drug Delivery Market Segmentation
- 6.1. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Formulation Type
- Device Type
- 6.2. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Plain Canister
- Coated Canister
- 6.3. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chronic Obstructive Pulmonary Disease
- Asthma
- Cystic Fibrosis
- Other Applications
- 6.4. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Home Care Settings
- 6.5. Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Formulation Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dry Powder Inhalers (DPIs)
- Metered Dose Inhalers (MDIs)
- Nebulizers
- Liquid Aerosols
- Nasal Sprays
- 6.6. Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Device Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Inhalers (Manual and Digital)
- Nebulizers (Compressor, Ultrasonic, Mesh)
- Breath-Activated Devices
- Spacer Devices
- Nasal Drug Delivery Devices
7. Pulmonary Or Respiratory Drug Delivery Market Regional And Country Analysis
- 7.1. Global Pulmonary Or Respiratory Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Pulmonary Or Respiratory Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market
- 8.1. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Pulmonary Or Respiratory Drug Delivery Market
- 9.1. China Pulmonary Or Respiratory Drug Delivery Market Overview
- 9.2. China Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Pulmonary Or Respiratory Drug Delivery Market
- 10.1. India Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Pulmonary Or Respiratory Drug Delivery Market
- 11.1. Japan Pulmonary Or Respiratory Drug Delivery Market Overview
- 11.2. Japan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Pulmonary Or Respiratory Drug Delivery Market
- 12.1. Australia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Pulmonary Or Respiratory Drug Delivery Market
- 13.1. Indonesia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Pulmonary Or Respiratory Drug Delivery Market
- 14.1. South Korea Pulmonary Or Respiratory Drug Delivery Market Overview
- 14.2. South Korea Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Pulmonary Or Respiratory Drug Delivery Market
- 15.1. Western Europe Pulmonary Or Respiratory Drug Delivery Market Overview
- 15.2. Western Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Pulmonary Or Respiratory Drug Delivery Market
- 16.1. UK Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Pulmonary Or Respiratory Drug Delivery Market
- 17.1. Germany Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Pulmonary Or Respiratory Drug Delivery Market
- 18.1. France Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Pulmonary Or Respiratory Drug Delivery Market
- 19.1. Italy Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Pulmonary Or Respiratory Drug Delivery Market
- 20.1. Spain Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market
- 21.1. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market Overview
- 21.2. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Pulmonary Or Respiratory Drug Delivery Market
- 22.1. Russia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Pulmonary Or Respiratory Drug Delivery Market
- 23.1. North America Pulmonary Or Respiratory Drug Delivery Market Overview
- 23.2. North America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Pulmonary Or Respiratory Drug Delivery Market
- 24.1. USA Pulmonary Or Respiratory Drug Delivery Market Overview
- 24.2. USA Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Pulmonary Or Respiratory Drug Delivery Market
- 25.1. Canada Pulmonary Or Respiratory Drug Delivery Market Overview
- 25.2. Canada Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Pulmonary Or Respiratory Drug Delivery Market
- 26.1. South America Pulmonary Or Respiratory Drug Delivery Market Overview
- 26.2. South America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Pulmonary Or Respiratory Drug Delivery Market
- 27.1. Brazil Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Pulmonary Or Respiratory Drug Delivery Market
- 28.1. Middle East Pulmonary Or Respiratory Drug Delivery Market Overview
- 28.2. Middle East Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Pulmonary Or Respiratory Drug Delivery Market
- 29.1. Africa Pulmonary Or Respiratory Drug Delivery Market Overview
- 29.2. Africa Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Pulmonary Or Respiratory Drug Delivery Market Competitive Landscape And Company Profiles
- 30.1. Pulmonary Or Respiratory Drug Delivery Market Competitive Landscape
- 30.2. Pulmonary Or Respiratory Drug Delivery Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
31. Pulmonary Or Respiratory Drug Delivery Market Other Major And Innovative Companies
- 31.1. 3M Company
- 31.2. Koninklijke Philips N.V.
- 31.3. GlaxoSmithKline
- 31.4. Omron Corporation
- 31.5. Teva Pharmaceutical Industries Ltd.
- 31.6. Aptar Pharma
- 31.7. Sumitomo Pharma America Inc.
- 31.8. Chiesi Farmaceutici S.p.A.
- 31.9. Cipla Inc.
- 31.10. Boehringer Ingelheim GmbH
- 31.11. Kindeva Drug Delivery Limited
- 31.12. Nemera Group
- 31.13. Hovione
- 31.14. H And T Presspart Group
- 31.15. Vectura Group plc
32. Global Pulmonary Or Respiratory Drug Delivery Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Pulmonary Or Respiratory Drug Delivery Market
34. Recent Developments In The Pulmonary Or Respiratory Drug Delivery Market
35. Pulmonary Or Respiratory Drug Delivery Market High Potential Countries, Segments and Strategies
- 35.1 Pulmonary Or Respiratory Drug Delivery Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Pulmonary Or Respiratory Drug Delivery Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Pulmonary Or Respiratory Drug Delivery Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
